{
    "id": "dbpedia_1725_3",
    "rank": 30,
    "data": {
        "url": "https://www.medschool.umaryland.edu/profiles/civin-curt/",
        "read_more_link": "",
        "language": "en",
        "title": "University of Maryland School of Medicine",
        "top_image": "https://www.medschool.umaryland.edu/media/som/assets/favicon/favicon-32x32.png",
        "meta_img": "https://www.medschool.umaryland.edu/media/som/assets/favicon/favicon-32x32.png",
        "images": [
            "https://www.medschool.umaryland.edu/media/som/assets/images/umsom-logo.png",
            "https://www.medschool.umaryland.edu/media/SOM/Faculty/Faculty-Profile-Graphics/edit-icon.png",
            "https://www.medschool.umaryland.edu/media/SOM/Faculty/Faculty-Profile-Graphics/edit-icon.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "https://www.medschool.umaryland.edu/media/som/assets/favicon/favicon-32x32.png",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Complete List of Published Work:\n\nhttps://www.ncbi.nlm.nih.gov/myncbi/curt.civin.1/bibliography/40991787/public/\n\nFelschow, D.M., Civin, C.I., Hoehn, G.T. Characterization of the Tyrosine Kinase Tnk1 and its Binding with Phosphalipase C-gamma1. Biochem Biophy Res Commun 273:294-301, 2000. PMID: 10873601\n\nCivin, C.I., Gene Therapy in Clinical Applications: Overview: How Do We Translate Gene Therapy to Clinical Trials? Stem Cells 18:150-156, 2000. PMID: 10742388\n\nCivin, C.I., Human Pluripotent Stem Cells: Science Fiction Poses No Immediate Danger. Stem Cells 18: iv-v, 2000. PMID: 11072037\n\nCivin, C.I., Young Turks Forum – for the Young and Young at Heart. Stem Cells 18:ii, 2000.\n\nCivin, C.I., A Challenge to Solve “Lichtman’s Riddles”. Stem Cells 18:iii, 2000. PMID: 11007927\n\nLoeb, D.M., Bowers, D.C., Civin, C.I., Friedman, A.D. Intensive Time Sequential Remission Induction Chemotherapy with High-Dose Cytarabine for Childhood Acute Myeloid Leukemia. Med Pediatr Oncol 37:365-371, 2001. PMID: 11568900\n\nFelschow, D.M., McVeigh, M.L., Hoehn, G.T., Civin, C.I., Fackler, M.J. The Adapter Protein CrkL Associates with CD34. Blood 97:3768-3775, 2001. PMID: 11389015\n\nGao, Z., Golob, J., Tanavde, V.M., Civin, C.I., Hawley, R.G., Cheng, L. High Levels of Transgene Expression Following Transduction of Long-Term NOD/SCID-Repopulating Cells with a Modified Lentiviral Vector. Stem Cells 19:247-259, 2001. PMID: 11389015\n\nGao, Z., Fackler, M.J., Leung, W., Lumkul, R., Ramirez, M., Theobald, N., Malech, H.L., Civin, C.I. Human CD34+ Cell Preparations Contain Over 100-fold Greater NOD/SCID Mouse Engrafting Capacity than do CD34- Cell Preparations. Exp Hematol 29:910-921, 2001. PMID: 11438214\n\nTse, K.F., Novelli, E., Civin, C.I., Bohmer, F.D., Small, D. Inhibition of FLT3-Mediated Transformation by use of a Tyrosine Kinase Inhibitor. Leukemia 15:1001-1010, 2001. PMID: 11455967\n\nCivin, C.I. Stem Cell Research: Back to the Future. Stem Cells 19:356-357, 2001. PMID: 11553844\n\nMason, D.Y., Andre, P., Bensussan, A., Buckley, Civin, C.I., C., Clark, E., De Haas, M., Goyert, S., Hadam, M., Hart, D., Horeist, V., Meuer, S., Morrissey, J., Schwartz-Albiez, R., Shaw, S., Simmons, D., Uguccioni, M., Van Der Schoot, E., Vivier, E., Zola, H. CD antigens 2001. Immunology 103:1-10, 2001. PMID: 11929596\n\nGorin, N.C., Piantadosi, S., Stull, M., Wingard, J.R., Civin, C.I. Increased Risk of Lethal Graft Versus Host Disease-Like Syndrome After Transplantation Into Nod/Scid Mice of Human Mobilized Peripheral Blood Stem Cells, as Compared to Bone Marrow or Cord Blood. J Hematother Stem Cell Res 11:277-292, 2002. PMID: 11983099\n\nKim, H.J., Whartenby, K.A., Georgantas, R.W., Wingard, J., Civin, C.I. Human CD34+ Hematopoietic Stem/Progenitor Cells Express High Levels of FLIP and are Resistant to Fas-Mediated Apoptosis. Stem Cells 20:174-182, 2002. PMID: 11897874\n\nYang, Y., Wang, W., Cleaves, R., Zahurak, M., Cheng, L., Civin, C.I., Friedman, A.D. Acceleration of G1 Cooperates with CBF-SMMHC to Induce Acute Leukemia in Mice. Cancer Res 62:2232-2235, 2002. PMID: 11956074\n\nTanavde, V.M., Malehorn, M.T., Lumkul, R., Gao, Z., Wingard, J., Garrett, E.S. Civin, C.I. Human Stem-Progenitor Cells from Neonatal Cord Blood Have Greater Hematopoietic Expansion Capacity than those from Mobilized Adult Blood. Exp Hematol 30:816-823, 2002. PMID: 12135681\n\nLumkul, R., Gorin, N.C., Malehorn, M.T., Hoehn, G.T., Zheng, R., Baldwin, B., Small, D., Gore, S., Smith, B.D., Meltzer, P.S., Civin, C.I. Human AML Cells in NOD/SCID Mice: Engraftment Potential and Gene Expression. Leukemia 16:1818-1826, 2002. PMID: 12200698\n\nBernardin, F., Yang, Y., Cleaves, R., Zahurak, M., Cheng, L., Civin, C.I., Friedman, A.D. TEL-AML1, Expressed From t(12;21) in Human Acute Lymphocytic Leukemia, Induces Acute Leukemia in Mice. Cancer Res 62:3904-3908, 2002. PMID: 12124316\n\nMason, D., Andre, P., Bensussan, A., Buckley, C., Civin, C.I., Clark, E., de Hass, M., Goyert, S., Hadam, M., Hart, D., Horeist, V., Meuer, S., Morrissey, J., Schwartz-Albiez, R., Shaw, S., Simmons, D., Uguccioni, M., Van Der Schoot, E., Vivier, E., Zola, H. CD Antigens 2002. Blood 99:3877-3880, 2002. PMID: 12014373\n\nCivin, C.I., Gewirtz, A.M. Stem Cells 20th Anniversary. Stem Cells 20:1-2, 2002.\n\nCivin, C.I. Commitment to Biomedical Research: Clearing Unnecessary Impediments to Progress. Stem Cells 20:482-484, 2002. PMID: 12456955\n\nWhartenby, K.A., Straley, E.E., Kim, H.J., Racke, F., Tanavde, V., Gorski, K.S., Cheng, L., Pardoll, D.M., Civin, C.I. Transduction of Donor Hematopoietic Stem-Progenitor Cells with Fas Ligand Enhanced Short-Term Engraftment in a Murine Model of Allogeneic Bone Marrow Transplantation. Blood 100:3147-3154, 2002. PMID: 12384412\n\nRoesler, J., Brenner, S., Bukovsky, A.A., Whiting-Theobald, N., Dull, T., Kelly, M., Civin, C.I., Malech, H.L. Third-generation, Self-Inactivating gp91(phox) Lentivector Corrects the Oxidase Defect in NOD/SCID Mouse-Repopulating Peripheral Blood-Mobilized CD34+ Cells from Patients with X-Linked Chronic Granulomatous Disease. Blood 100:4381-4390, 2002. PMID: 12393624\n\nChute, J.P., Saini, A.A., Chute, D.J., Wells, M.R., Clark, W.B., Harlan, D.M., Park, J., Stull, M.K., Civin, C.I., Davis, T.A. Ex vivo Culture with Human Brain Endothelial Cells Increases the SCID-Repopulating Capacity of Adult Human Bone Marrow. Blood 100:4433-4439, 2002. PMID: 12393435\n\nBernardin, F., Yang, Y., Civin, C.I., Friedman, A.D. c-Myc Overcomes Cell Cycle Inhibition by CBFbeta-SMMHC, a Myeloid Leukemia Oncoprotein. Cancer Biol. Ther. 1:492-494, 2002. PMID: 12496475\n\nAngelopoulou, M., Novelli, E., Grove, J.E., Rinder, H.M., Civin, C.I., Cheng, L., Krause, D. Cotransplantation of Human Mesenchymal Stem Cells Enhances Human Myelopoiesis and Megakaryocytopoiesis in NOD/SCID Mice. Exp Hematol 31:413-420, 2003. PMID: 12763140\n\nYu X., Zhan X., D’Costa J., Tanavde V.M., Ye Z., Peng T., Malehorn M.T., Yang X., Civin C.I., Cheng L. Lentiviral Vectors with Two Independent Internal Promoters Transfer High-Level Expression of Multiple Transgenes to Human Hematopoietic Stem-Progenitor Cells. Mol Ther 7:827-838, 2003. PMID: 12788657\n\nCivin, C.I., Gewirtz, A.M., Hawley, R.G. Stem Cells: 21 Years Old, with the Best Yet to Come. Stem Cells 21:513, 2003.\n\nCui Y., Kelleher E., Straley E., Fuchs E., Gorski K., Levitsky H., Borrello I., Civin C.I., Schoenberger S., Cheng L., Pardoll D.M., Whartenby K.A. Immunotherapy of Established Tumors Using Bone Marrow Transplantation With Antigen Gene--Modified Hematopoietic Stem Cells. Nat Med 9:952-958, 2003.PMID: 12778137\n\nDunlap S., Yu X., Cheng L., Civin C.I., Alani RM. High-Efficiency Stable Gene Transduction in Primary Human Melanocytes Using a Lentiviral Expression System. J Invest Dermatol 122:549-551, 2004. PMID: 15009744\n\nCivin, C.I., Gewirtz, A.M., Hawley, R.G. Editors’ note for 2004. Stem Cells 22:1, 2004.\n\nPalaganas, J., Civin, C.I. Two Steps Forward: Keeping the Momentum in Stem Cell Research. Stem Cells 22:240-241, 2004. PMID: 15153598\n\nCivin, C.I., STEM CELLS: Some Good News. Stem Cells 22:648, 2004.\n\nBohana-Kashtan, O., Civin, C.I. Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance. Stem Cells 22:908-924, 2004. PMID: 15536183\n\nCivin, C.I. Whither STEM CELLS? Stem Cells 22:1127, 2004.\n\nCivin, C.I. CD34: Conception to Birth. ISCT Telegraft 11:1-2, 2004.\n\nMatsui W, Huff C.A., Wang Q., Malehorn M.T., Barber J., Tanhehco Y., Smith B.D., Civin C.I., Jones R.J. Characterization of Clonogenic Multiple Myeloma Cells. Blood 103:2332-2336, 2004. PMID: 14630803\n\nGeorgantas R.W., Tanavde V., Malehorn M, Heimfeld S., Chen C., Carr L, Murillo F, Riggins G, Civin C.I. Microarray and Serial Analysis of Gene Expression Analyses Identify Known and Novel Transcripts Overexpressed in Hematopoietic Stem Cells. Cancer Res 64:4434-4441, 2004. PMID: 15231652\n\nLewis L.D., Amin S., Civin C.I., Leitman P.S. Ex Vivo Zidovudine (AZT) Treatment of CD34+ Bone Marrow Progenitors Causes Decreased Steady State Mitochondrial DNA (mtDNA) and INcreased Lactate Production. Hum Exp Toxicol 23:173-185, 2004. PMID: 15171568\n\nTopaloglu O., Civin C.I., Bunz F. Digital HLA Allelotyping. Cancer Biol 3:899-902, 2004. PMID: 15326386\n\nEsni F., Ghosh B., Biankin A.V., Lin J.W., Albert M.A., Yu X, MacDonald R.J., Civin C.I., Real F.X., Pack M.S., Ball D.W., Leach S.D. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Develop 131:4213-4224, 2004. PMID: 15280211\n\nD'Costa J., Chaudhuri S., Civin C.I., Friedman A.D. CBFbeta-SMMHC slows proliferation of primary murine and human myeloid progenitors. Leukemia 19:921-929, 2005. PMID: 15815715\n\nZambidis, E.T., Peault B., Park T.S., Bunz F., Civin C.I. Hematopoietic Differentiation of Human Embryonic Stem Cells Progresses Through Sequential Hematoendothelial, Primitive, and Definitive Stages Resembling Human Yolk Sac Development. Blood 106:860-870, 2005. PMID: 15831705\n\nCivin, C.I., Gewirtz, A.M., Hawley, R.G., Goodell, M.A Advancing the Fast-Paced Field of Stem Cell Research: Stem Cells Increases from 6 to 10 Issues in its 23rd Year of Publication. Stem Cells 23:1-2, 2005. PMID: 15625117\n\nBohana-Kashtan O., Civin C.I. Profiling Tumor Counterattack: Do Fas Ligand-Containing Microvesicles Reduce Anticancer Immunity? Clin Cancer Res 11:968-970, 2005. PMID: 15709161\n\nRao M.S., Civin C.I. Translational Research: Toward Better Characterization of Human Embryonic Stem Cells Lines. Stem Cells 23:1453, 2005. PMID: 16293580\n\nTopaloglu O., Hurley P.J., Yildirim O., Civin C.I., Bunz F. Improved Methods for the Generation of Human Gene Knockout and Knockin Cell Lines. Nucleic Acids Res. 33:158, 2005. PMID: 16214806\n\nRavindranath Y., Chang M., Steuber C.P., Becton D., Dahl G., Civin C.I., Camitta B., Carroll A., Raimondi S.C., Weinstein H.J. Pediatric Oncology Group (POG) Studies of Acute Myeloid Leukemia (AML): a Review of Four Consecutive Childhood AML Trials Conducted Between 1981 and 2000. Leukemia 19:2101-2116, 2005. PMID: 16136167\n\nBala P., Georgantas R.W. 3rd, Sudhir D., Suresh M., Shanker K., Vrushabendra B.M., Civin C.I., Pandey A. TAGmapper: A Web-Based Tool for Mapping SAGE Tags. Gene 364:123-129, 2005. PMID: 16112519\n\nZhang L., D'Costa J., Kummalue T., Civin C.I., Friedman A.D. Identification of a Region on the Outer Surface of the CBFbeta-SMMHC Myeloid Oncoprotein Assembly Competence Domain Critical for Multimerization. Oncogene 25:7289-7296, 2006. PMID: 16767164\n\nMcNiece I., Civin C.I., Harrington J., Kellner J., Malehorn M., Turney J., Barber J., Jones R. Ex vivo expansion of mafosfamide-purged PBPC products. Cytotherapy. 8:459-64, 2006. PMID: 17050250\n\nCivin C.I., Rao M.S. How Many Embryonic Stem Cell Lines Are Sufficient? A U.S. Perspective. Stem Cells 24:800-803, 2006. PMID: 16543487\n\nCivin, C.I. Editorial Retraction. Stem Cells 24:804, 2006. PMID: 16582451\n\nCivin, C.I. Troublesome Questions. Stem Cells 24:1411, 2006. PMID: 16687465\n\nCivin, C.I. Stem Cell’s Impact Continues its Ascent. Stem Cells 24:1993-94, 2006.\n\nYu X., Alder J.K., Chun J.H., Friedman A.D., Heimfeld S., Cheng L., Civin C.I HES1 Inhibits Cycling of Hematopoietic Progenitor Cells Via DNA Binding. Stem Cells 24:876-888, 2006 PMID: 16513761\n\nWang D., D’Costa J., Civin C.I., Friedman A.D. C/EBPalpha Directs Monocytic Commitment of Primary Myeloid Progenitors. Blood 108:1223-1229, 2006. PMID: 16645168 PMCID: PMC1895870\n\nGeorgantas R.W., 3rd, Bohana-Kashtan O., Civin C.I. Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease. Transplantation 82:471-478, 2006. PMID: 16926590\n\nGeorgantas R.W., 3rd, Hildreth R., Morisot S., Alder J., Liu C.G., Heimfeld S., Calin G.A., Croce CM, Civin C.I. CD34+ Hematopoietic Stem-Progenitor Cell MicroRNA Expression and Function: a Circuit Diagram of Differentiation Control. Proc Natl Acad Sci 104:2750-2755, 2007. PMID: 17293455 PMCID: PMC1796783\n\nAlder J.K., Georgantas R.W., Hildreth R.L., Kaplan I.M., Morisot S., Yu X., McDevitt M., Civin C.I. Kruppel-Like Factor 4 is Essential for Inflammatory Monocyte Differentiation in Vivo. J Immunol 180:5645-5652, 2008. PMID: 18390749 PMCID: PMC3074963\n\nYu X., Zou J., Ye Z., Hammond H., Chen G., Tokunaga A., Mali P., Li Y.M., Civin C.I., Gaiano N., Cheng L. Notch Signaling Activation in Human Embryonic Stem Cells is Required for Embryonic, but not Trophoblastic, Lineage Commitment. Cell Stem Cell 1:461-471, 2008. PMID: 18462696 PMCID: PMC2442567\n\nBohana-Kashtan O., Morisot S., Hildreth R., Brayton C., Levitsky H.I, Civin C.I. Selective Reduction of Graft-Versus-Host Disease-Mediating Human T Cells By Ex Vivo Treatment with Soluble Fas Ligand. J Immunol 183:696-705, 2009. PMID: 19535642 PMCID: PMC3072680\n\nKandavelou K., Ramalingam S., London V, Mani M., Wu J., Alexeev V., Civin C.I., Chandrasegaran S. Targeted Manipulation of Mammalian Genomes Using Designed Zinc Finger Nucleases. Biochem Biophys Res Commun 388:56-61, 2009. PMID: 19635463 PMCID: PMC2744961\n\nHuang C.R., Schneider A.M., Lu Y., Niranjan T., Shen P., Robinson M.A., Steranka J.P., Valle D., Civin C.I., Wang T., Wheelan S.J., Ji H., Boeke J.D., Burns K.H. Mobile Interspersed Repeats are Major Structural Variants in the Human Genome. Cell 141:1171-1182, 2010. PMID: 20602999 PMCID: PMC2943426\n\nMorisot S., Wayne, A.S., Bohana-Kashtan, O., Kaplan, I.M., Gocke, C.D., Hildreth, R., Stetler-Stevenson, M., Walker, R.L., Davis, S., Meltzer, P.S., Wheelan, S.J., Brown, P., Jones, R.J., Shultz, L.D., Civin, C.I. High Frequencies of Leukemia Stem Cells in Poor-Outcome Childhood Precursor-B Acute Lymphoblastic Leukemias. Leukemia 11:1859-1866, 2010. PMID: 20739953 PMCID: PMC3035974\n\nCivin C.I. 2009 Landsteiner Lecture: CD34 Stem Cell Stories and Lessons from the CD34 Wars. Transfusion 50:2040-2056, 2010. PMID: 20561292\n\nLebson L., Gocke, A, Rosenzweig, J., Alder, J., Civin C.I., Calabresi, P.A., Whartenby, K.A. Cutting edge: The Transcription Factor Kruppel-Like Factor 4 Regulates the Differentiation of Th17 Cells Independently of RORgammat. J Immunol 12:7161-7164, 2010. PMID: 21076063 PMCID: PMC3071015\n\nKaplan I.M., Morisot, S., Heiser, D., Cheng, W.C., Kim, M.J., Civin C.I. Deletion of Tristetraprolin Caused Spontaneous Reactive Granulopoiesis by a Non-Cell-Autonomous Mechanism Without Disturbing Long-Term Hematopoietic Stem Cell Quiescence. J Immunol 1865:2826-2834, 2011. PMID: 21270394 PMCID: PMC3114656\n\nZhang H., Cui, Y., Voong, N., Sabatino, M., Stroncek, D.F., Morisot, S., Civin C.I., Wayne, A.S., Levine, B.L., Mackall, C.L. Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells. J Immunother 2:187-195, 2011. PMID: 21304401 PMCID: PMC3128544\n\nYu D., Zhan X.H., Zhao X.F., Williams M.S., Carey G.B., Smith E., Scott D., Zhu J., Guo Y., Cherukuri S., Civin C.I., Zhan X. Mice Deficient in MIM Expression are Predisposed to Lymphomagenesis. Oncogene 30:3561-8, 2012. PMID: 22081072 PMCID: PMC3350826\n\nSharkis S.J., Jones R.J., Civin C.I., Jang Y.Y. Pluripotent Stem Cell-Based Cancer Therapy: Promise and Challenges. Sci Transl Med 4:127, 2012. PMID: 22461639 PMCID: PMC3397797\n\nPrince O.D., Langdon J.M., Layman, A., Prince I.C., Sabogal M., Mak H.H., Berger A.E, Cheadle C., Chrest F.J., Yu Q., Andrews N.C., Civin C.I., Walston J.D., Roy C.N. Late Stage Erythroid Precursor Production is Impaired in Mice with Chronic Inflammation. Haematol 11:1648-58, 2012. PMID: 22581006 PMCID: PMC3487436\n\nScheibner K.A., Teaboldt B., Hauer M.C., Chen X., Cherukuri S., Guo Y., Kelley S.M., Liu Z., Baer M.R., Heimfeld S., Civin C.I. MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3theta. PLoS One 7:e50895, 2012. PMID: 23236401 PMCID: PMC3517479\n\nGodsey B., Heiser D., Civin C.I. Inferring MicroRNA Regulation of mRNA with Partially Ordered Samples of Paired Expression Data and Exogenous Prediction Algorithms. PLoS One 7:e51480, 2012. PMID: 23284698 PMCID: PMC3526609\n\nChu S.H., Heiser D., Li L., Kaplan I., Collector M., Huso D., Sharkis S.J., Civin C.I., Small D. FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm. Cell Stem Cell 11:346-358, 2012. PMID: 22958930 PMCID: PMC3725984\n\nRamalingam S., London V., Kandavelou K., Cebotaru L., Guggino W., Civin C.I., Chandrasegaran S. Generation and Genetic Engineering of Human Induced Pluripotent Stem Cells Using Designed Zinc Finger Nucleases. Stem Cells Dev 22:595-610, 2013. PMID: 22931452 PMCID: PMC3565436\n\nFarrance, I.K., Civin, C.I. Biochemistry and Signaling in Stem Cells, and Vice Versa. Biochim Biophys Acta 1830:2267, 2013. PMID: 23331875\n\nCheng W.C., Kingsbury T.J., Wheelan S.J., Civin C.I. A Simple High-throughput Technology Enables Gain-of-function Screening of Human microRNAs. BioTechniques 54:77-86, 2013. PMID: 23384178 PMCID: PMC3671589\n\nMott B.T., He R., Chen X., Fox J.M., Civin C.I., Arav-Boger R., Posner G.H. Artemisinin-Derived Dimer Phosphate Esters as Potent Anti-Cytomegalovirus (Anti-CMV) and Anti-Cancer Agents: A Structure-Activity Study. Bioorg Med Chem 21:3701-7, 2013. PMID: 23673218 PMCID: PMC3685872\n\nCramer-Morales K., Nieborowska-Skorska M., Scheibner K., Padget M., Irvine D., Sliwinski T., Haas K., Lee J., Roy D., Slupianek A., Waski M., Childers W., Copland M., Muschen M., Civin C.I., Skorski T. Personalized Synthetic Lethality Induced by Targeting RAD52 in Leukemias Identified by Gene Mutation and Expression Profile. Blood 122:1293-304, 2013. PMID: 23836560 PMCID: PMC3744994\n\nMcCranor B.J., Langdon J.M., Prince O.D., Femnou L.K., Berger A.E., Cheadle C., Civin C.I., Kim A., Rivera S., Ganz T., Vaulont S., Xue Q.L., Walston J.D., Roy C.N. Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age. Haematologica 98:1633-40, 2013. PMID: 23996485 PMCID: PMC3789470\n\nMcCranor B.J., Kim M.J., Cruz N.M., Xue Q.L., Berger A.E., Walston J.D., Civin C.I., Roy C.N. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis 52:126-33, 2014. PMID: 24119518 PMCID: PMC3947197\n\nLangdon J.M., Yates S.C., Laurette K., Femnou L.K., McCranor B.J., Qian-Li X., Vaulont S., Civin C.I., Walston J.D., Roy C.N. Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol 89:470-9, 2014. PMID: 24415655 PMCID: PMC4200395\n\nHeiser D., Tan Y.S., Kaplan I., Godsey B., Morisot S., Cheng W.C., Small D., Civin C.I. Correlated miR-mRNA expression signatures of mouse hematopoietic stem and progenitor cell subsets predict “stemness” and “myeloid” interaction networks. PLoS One 9:e94852, 2014. PMID: 24747944 PMCID: PMC3991639\n\nKim M.J., Tan Y.S., Cheng W.C., Kingsbury T.J., Heimfeld S., Civin C.I. MiR-144 and miR-451 regulate human erythropoiesis via RAB14. Br J Haematol 168:583-597, 2015. PMID: 25312678; PMCID: PMC4314389\n\nTan Y.S., Kim M.J., Kingsbury T.J., Civin C.I., Cheng W.C. Regulation of RAB5C is important for the growth inhibitory effects of miR-509 in human precursor-B acute lymphoblastic leukemia. PLoS One 9:e111777, 2014. PMID: 25368993 PMCID: PMC4219775\n\nHuang T.C., Cutler J., Bharne S., Zhong J., Weinstock D., Tyner J., Gojo I., Civin C.I., Pandey A. Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-Like Kinase 1 as a potential therapeutic target. Leuk Lymphoma 56:1524-7, 2015. PMID: 25213184 PMCID: PMCID: PMC4420723\n\nHuang T.C., Renuse S., Pinto S., Kumar P., Yang Y., Cherkady R., Godsey B., Mendell J.T., Halushka M.K., Civin C.I., Marchionni L., Pandey A. Identification of miR-145 targets through an integrated omics analysis. Mol Biosyst 11:197-207, 2015. PMID: 25354783 PMCID: PMC4352311\n\nMuvarak N., Kelley S., Robert C., Baer M.R., Perrotti D., Gambacorti-Passerini C., Civin C., Scheibner K., Rassool, F.V. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias. Mol Cancer Res 13:699-712, 2015. PMID: 25828893 PMCID: PMC4398615\n\nCandia J., Cherukuri S., Guo Y., Doshi K., Banavar J.R., Civin C.I., Losert W. Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine learning-driven network approach. Converg Sci Phys Oncol 1:025002, 2015. doi:10.1088/2057-1739/1/2/025002.\n\nFurusawa A., Sadashivaiah K., Singh Z.N., Civin C.I., Banerjee A. Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet. Exp Hematol 44:194-206, 2016. PMID: 26607595 PMCID: PMC4789076\n\nFox J.M., Moynihan J.R., Mott B.T., Mazzone J.R., Anders N.M., Brown P.A., Rudek M.A., Liu J.O., Arav-Boger R., Posner G.H., Civin C. I., Chen X. Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. Oncotarget 7:7268-7279, 2016. PMID: 26771236 PMCID: PMC4872784\n\nZhan T., Cao C., Li L., Gu N., Civin C.I., Zhan X. MIM regulates the trafficking of bone marrow vells via modulating surface expression of CXCR4. Leukemia 30:1327-34, 2016. PMID: 26965284 PMCID: PMC4889520\n\nCivin C.I., Ward T., Skelley A.M., Gandhi K., Lee Z.P., Dosier C.R., D’Silva J.L., Chen Y., Kim M.J., Moynihan J., Chen X., Aurich L., Gulnik S., Brittain G.C., Recktenwald D., Austin R.H., Sturm J.C. Automated Leukocyte Processing by Microfluidic Deterministic Lateral Displacement. Cytometry A 89:1073-83, 2016. PMID: 27875619 PMCID: PMC5488292\n\nNieborowska-Skorska M., Sullivan K., Dasgupta Y., Podszywalow-Bartnicka P., Hoser G., Maifrede S., Martinez E., Marcantonio D.D., Bolton E., Cramer K., Lee J.W., Li S.M, Slupianek A., Gritsyuk D. Cerny-Reiterer S., Seferynska I., Stoklosa T., Bullinger L. Zhao H., Gorbunova V., Piwocka K., Valent P., Civin C., Muschen M., Dick J.E., Wang J.C.Y., Bhatia S., Bhatia R., Eppert K., Minden M.D., Sykes S., Skorski T. Personalized Medicine-guided Synthetic Lethality Eradicates Proliferating and Quiescent Leukemia Cells. J Clin Invest 127:2392-2406, 2017. PMID: 28481221 PMCID: PMC5451241\n\nSasaki T., Rivera-Mulial J.C., Vera D., Zimmerman J., Das S., Padget M., Nakamichi N., Chang B.H., Tyner J., Druker B.J., Weng A.P., Civin C.I., Eaves, C.J., Gilbert, D.M. Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. Exp Hematol 51:71-82, 2017. PMID: 28433605 PMCID: PMC5491210\n\nCampos-González R., Skelley A.M., Gandhi K., Inglis D.W., Sturm J.C., Civin C.I., Ward T. Deterministic Lateral Displacement: The Next Generation CAR T-Cell Processing? SLAS Technol 23:338-351, 2018. PMID: 29361868\n\nSimpson H.M., Furusawa A., Sadashivaiah K., Civin C.I., Banerjee A. STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma. Oncotarget 9:16792-806, 2018. PMID: 29682185 PMCID: PMC5908286\n\nLembong J., Lerman M.J., Kingsbury T.J., Civin C.I., Fisher J.P. A fluidic culture platform for spatially patterned cell growth, differentiation, and cocultures. Tissue Eng Part A 24:1715-32, 2018. PMID: 29845891\n\nKim M.J., Civin C.I., Kingsbury T.J. MicroRNAs as regulators and effectors of hematopoietic transcription factors. WIREs RNA 10:e1537, 2019. PMID: 31007002\n\nCreed M., Baldeosingh R., Eberly C.L., Schlee C.S., Kim M.J., Cutler J.A., Pandey A., Civin C.I., Fossett N.G., Kingsbury T.J. PAX-SIX-EYA-DACH Network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis. Development 147:dev177022, 2020. doi:10.1242/dev.177022. PMID: 31806659 PMCID: PMC6983716\n\nEmadi A., Kapadia B., Bollino D., Bhandary B., Baer M.R., Niyongere S., Strovel E.T., Kaizer H., Chang E., Choi E.Y., Ma X., Tighe K.M., Carcer-Cooper B., Moses B.S., Civin C.I., Mahurkar A., Shetty A.C., Gartenhaus R.B., Kamangar F., Lapidus R.G. Venetoclax and pegcrisantaspase for complex karyotype acute leukemia. Leukemia 16:Doi: 10.1038/s41375-020-01080-6, 2021. PMID: 33199836 PMCID:\n\nMoses B., McCullough S., Fox J.M., Mott B., Bentzen S., Kim M.J., Tyner J.W., Lapidus R.G., Emadi A., Rudek M., Kingsbury T., Civin C.I. Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax. Blood Adv 5:711-724, 2021. PMID: 33560385 PMCID: PMC7876886\n\nSaha P., Kim M., Tulshyan A., Guo Y., Mishra R., Li D., Civin C.I., Kaushal S., Sharma S. Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells. J Thorac Cardiovasc Surg, 2021; S0022-5223(21)01046-1. PMID: 34465468\n\nKagan A.B., Moses B.S., Mott B.T., Rai G., Anders N.M., Rudek M.A., Civin C.I. A Novel 2-Carbon-Linked Dimeric Artemisinin with Potent Antileukemic Activity and Favorable Pharmacology. Front Oncol. 2022;11:790037. Published 2022 Jan 11. DOI: 10.3389/fonc.2021.790037. PMID: 35127495 PMCID: PMC8811960\n\nGunasekaran M., Mishra R., Progyaparamita S., Morales D., Cheng W.C., Jayaraman A.R., Hoffman J.R., Davidson L., Chen L. Shah A.M., Bittle G., Fu X., Tulshyan A., Abdullah M., Kingsbury T., Civin C., Yang P., Davis M.E., Bolli R., Hare J.M., Sharma S., Kaushal S. Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury. iScience 2022;25(8):104656. Published 2022 Jun 22. DOI: 10.1016/j.isci.2022.104656. PMID: 35847554 PMCID: PMC9283895"
    }
}